Nicholas Keen - Net Worth and Insider Trading

Nicholas Keen Net Worth

The estimated net worth of Nicholas Keen is at least $2 Million dollars as of 2024-11-13. Nicholas Keen is the CHIEF SCIENTIFIC OFFICER of Bicycle Therapeutics PLC and owns about 69,024 shares of Bicycle Therapeutics PLC (BCYC) stock worth over $2 Million. Details can be seen in Nicholas Keen's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Nicholas Keen has not made any transactions after 2024-07-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Nicholas Keen

To

Nicholas Keen Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Nicholas Keen owns 1 companies in total, including Bicycle Therapeutics PLC (BCYC) .

Click here to see the complete history of Nicholas Keen’s form 4 insider trades.

Insider Ownership Summary of Nicholas Keen

Ticker Comapny Transaction Date Type of Owner
BCYC Bicycle Therapeutics PLC 2024-07-03 Chief Scientific Officer

Nicholas Keen Latest Holdings Summary

Nicholas Keen currently owns a total of 1 stock. Nicholas Keen owns 69,024 shares of Bicycle Therapeutics PLC (BCYC) as of July 3, 2024, with a value of $2 Million.

Latest Holdings of Nicholas Keen

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BCYC Bicycle Therapeutics PLC 2024-07-03 69,024 23.52 1,623,444

Holding Weightings of Nicholas Keen


Nicholas Keen Form 4 Trading Tracker

According to the SEC Form 4 filings, Nicholas Keen has made a total of 12 transactions in Bicycle Therapeutics PLC (BCYC) over the past 5 years, including 0 buys and 12 sells. The most-recent trade in Bicycle Therapeutics PLC is the sale of 779 shares on July 3, 2024, which brought Nicholas Keen around $15,300.

Insider Trading History of Nicholas Keen

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Nicholas Keen Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Nicholas Keen Ownership Network

Ownership Network List of Nicholas Keen

No Data

Ownership Network Relation of Nicholas Keen

Insider Network Chart

Nicholas Keen Owned Company Details

What does Bicycle Therapeutics PLC do?

Who are the key executives at Bicycle Therapeutics PLC?

Nicholas Keen is the Chief Scientific Officer of Bicycle Therapeutics PLC. Other key executives at Bicycle Therapeutics PLC include Chief Business Officer Nigel Crockett , Chief Accounting Officer Travis Alvin Thompson , and Chief Operating Officer Alistair Milnes .

Bicycle Therapeutics PLC (BCYC) Insider Trades Summary

Over the past 18 months, Nicholas Keen made 5 insider transaction in Bicycle Therapeutics PLC (BCYC) with a net sale of 4,817. Other recent insider transactions involving Bicycle Therapeutics PLC (BCYC) include a net sale of 21,235 shares made by Kevin Lee , a net sale of 6,430 shares made by Michael Skynner , and a net sale of 6,430 shares made by Nigel Crockett .

In summary, during the past 3 months, insiders sold 6,528 shares of Bicycle Therapeutics PLC (BCYC) in total and bought 0 shares, with a net sale of 6,528 shares. During the past 18 months, 47,264 shares of Bicycle Therapeutics PLC (BCYC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 47,264 shares.

Bicycle Therapeutics PLC (BCYC)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Bicycle Therapeutics PLC Insider Transactions

No Available Data

Nicholas Keen Mailing Address

Above is the net worth, insider trading, and ownership report for Nicholas Keen. You might contact Nicholas Keen via mailing address: C/o Bicycle Theapeutics Limited, B900 Babraham Research Campus, Cambridge X0 Cb22 3at.